Heart Failure With Preserved Ejection Fraction trials recruiting in Indiana

All Heart Failure With Preserved Ejection Fraction trials nationally

Cities in Indiana

Recruiting trials in Indiana

• A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
  NCT07795814 · Phase: Phase 2 · Ages: 30 Years to 84 Years · Sex: All (male and female) · Indiana: Indianapolis
• Assessment of CCM in HF With Higher Ejection Fraction
  NCT05064709 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Indiana: Indianapolis
• Leg Heat Therapy in Heart Failure With Preserved Ejection Fraction
  NCT06388226 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Indiana: Indianapolis
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Indiana: Elkhart, Indianapolis, Munster, Richmond
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
  NCT02901184 · Phase: Phase 3 · Ages: 50 Years to 99 Years · Sex: All (male and female) · Indiana: Indianapolis